Noninvasive Blood Test Launched for Myeloma MRD Monitoring
Quest Diagnostics has launched a new blood-based test—Quest Flow Cytometry MRD for Myeloma—to monitor measurable residual disease (MRD) in multiple myeloma patients across the U.S. The test uses advanced flow cytometry […]






